Health Canada Issues Recall for JAMP Pharma’s Acetaminophen and Other Products
Health Canada has recently announced a significant recall affecting a range of products from JAMP Pharma, a well-known Canadian pharmaceutical brand. This recall includes both acetaminophen and vitamin supplements, raising concerns about potential risks to consumers.
The recall notice highlights issues with several products from JAMP Pharma. Notably, the Vitamin D3 10,000-unit tablets have been flagged. The affected lot numbers for these tablets are EG24CHH002, EG24CHI001, EG24CHI002, and EG24CHI003. The recall is due to concerns that some of these tablets may be improperly dosed, either being overweight or underweight.
Also Read:- Kate Garraway Delivers Heartfelt Speech at NTAs with Children by Her Side
- Malaika Arora's Father Anil Mehta's Last Words Revealed Before Tragic Death
Acetaminophen, a common over-the-counter medication used to alleviate pain and reduce fever, is also included in this recall. The affected acetaminophen products are both the 325 milligram tablets and the extra strength 500 milligram tablets. This recall is particularly concerning as acetaminophen is widely used to treat a variety of conditions including headaches, muscle pain, and osteoarthritis. Incorrect dosages could potentially lead to adverse health effects, making it critical for users to check if their medications are part of this recall.
In addition to the acetaminophen and vitamin D3 tablets, JAMP Pharma's telmisartan tablets are also affected. Telmisartan, available in 40 mg and 80 mg doses, is typically prescribed for managing high blood pressure and reducing the risk of heart attacks and strokes. The recall notice does not specify the exact issues with these tablets, but it is crucial for patients using this medication to verify if their lot numbers are included in the recall.
Health Canada is urging consumers who have purchased these affected products to check their medications and consult with their healthcare providers before stopping use. This step is essential to ensure that individuals do not inadvertently stop a necessary treatment or mistakenly assume their medication is safe without proper guidance.
For further information or to address any concerns regarding the recall, individuals are advised to contact JAMP Pharma directly. Health Canada also encourages reporting any adverse effects or issues experienced with the recalled products to help ensure public safety.
This recall underscores the importance of remaining vigilant about medication safety and keeping informed about potential health risks.
Read More:
0 Comments